Mylan Dymista Nasal Spray Recall: Broken Glass Risk
Mylan recalls Dymista nasal spray due to potential broken glass in bottle necks. Stop using if you have this product.
Use caution until it’s fixed
Defective Container: Potential for broken glass in the neck area of the glass bottles.
Contact the company
What happened, in plain English
Mylan is recalling Dymista nasal spray because glass bottles might break in the neck area. This could cause injury if the broken glass is inhaled or comes into contact with the nasal passages. Read more at govinfonow.com/recall/39217-mylan-dymista-nasal-spray-recall-broken-glass-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39217-mylan-dymista-nasal-spray-recall-broken-glass-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0424-2019
Cite this page
“Mylan Dymista Nasal Spray Recall: Broken Glass Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39217-mylan-dymista-nasal-spray-recall-broken-glass-risk. Based on FDA recall #D-0424-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0424-2019%22&limit=1).
Why it’s dangerous
The glass bottles in the neck area may break, creating small glass fragments. If these fragments are inhaled or touch the nasal passages, they could cause injury or irritation.
Who’s affected
People with the recalled Dymista nasal spray (137 mcg/50 mcg per spray, 120 metered) who have a prescription. Those with sensitive nasal passages or who use the spray frequently are at higher risk.
How to tell if you have this one
Check for the Dymista nasal spray with 137 mcg/50 mcg per spray, 120 metered sprays, 23 g net weight, and a lot number of GA70535 (expiring April 2019). This product is prescription-only.
- Brand
Mylan- Category
Drug
What to do — step by step
Stop Using Now
If you have the recalled Dymista nasal spray, stop using it immediately to avoid potential injury from broken glass.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Mylan recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0424-2019 (February 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0424-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.